Afiqa Aulia

aku mencintaimu

[Afiqa Aulia @afiqau12]

@LifeNetwork_AI B

[Afiqa Aulia @afiqau12]

LifeAI helps people stay healthier with intelligent alerts.
@LifeNetwork_AI #LifeAI #healthcareAI https://t.co/5cB3ZW0Vdr

[LIFE AI @LifeNetwork_AI]

🩺 Community Question

Should preventive healthcare justify large-scale investment and widespread adoption?

Viewpoint A:
Preventive care involves significant upfront costs and carries risks of overdiagnosis and overtreatment, potentially increasing anxiety and spending without clear mortality gains.

Viewpoint B:
Prevention through screening and lifestyle interventions can reduce disease burden, hospitalizations, and long-term costs, while improving life expectancy and quality of life.

Is prevention a cost-effective long-term strategy or an overextended approach with uncertain net benefit?

👇 Drop A, B, or share your perspective.

[LIFE AI @LifeNetwork_AI]

🩺 Community Question

Should preventive healthcare justify large-scale investment and widespread adoption?

Viewpoint A:
Preventive care involves significant upfront costs and carries risks of overdiagnosis and overtreatment, potentially increasing anxiety and spending without clear mortality gains.

Viewpoint B:
Prevention through screening and lifestyle interventions can reduce disease burden, hospitalizations, and long-term costs, while improving life expectancy and quality of life.

Is prevention a cost-effective long-term strategy or an overextended approach with uncertain net benefit?

👇 Drop A, B, or share your perspective.

[아라자에스 💜 @arazzaez]

$WhiteWhale The controller of the moon 🌕🚀🐋

[아라자에스 💜 @arazzaez]

Trying to post a video on @agentgram_ ! 🦞

https://t.co/QTUcxA66cA

[Afiqa Aulia @afiqau12]

@LifeNetwork_AI B

[Afiqa Aulia @afiqau12]

LifeAI revolutionizes health monitoring with precision and transparency.
#healthcareAI @LifeNetwork_AI #LifeAI https://t.co/As3lhMuNJ4

[LIFE AI @LifeNetwork_AI]

🩺 Community Question:
Elon Musk recently said that, based on current human constraints, AI-powered robotics could become better surgeons than the best human surgeons within three years at scale.

Do you agree with him?

Viewpoint A:
Agree. With few great surgeons, slow and costly human training, and unavoidable human error, AI and robotics could learn faster and scale surgical skill beyond human limits.

Viewpoint B:
Disagree. Even acknowledging the human constraints Elon Musk points out, surgery is not only about speed, scale, or error reduction. It also depends on judgment, responsibility, and trust in high-stakes situations, which remain difficult to validate and deploy safely at scale.

Is this a near-term breakthrough or a vision that overestimates how quickly surgical autonomy can be safely scaled?

👇 Drop A, B, or share your perspective.

[LIFE AI @LifeNetwork_AI]

🩺 Community Question:
Elon Musk recently said that, based on current human constraints, AI-powered robotics could become better surgeons than the best human surgeons within three years at scale.

Do you agree with him?

Viewpoint A:
Agree. With few great surgeons, slow and costly human training, and unavoidable human error, AI and robotics could learn faster and scale surgical skill beyond human limits.

Viewpoint B:
Disagree. Even acknowledging the human constraints Elon Musk points out, surgery is not only about speed, scale, or error reduction. It also depends on judgment, responsibility, and trust in high-stakes situations, which remain difficult to validate and deploy safely at scale.

Is this a near-term breakthrough or a vision that overestimates how quickly surgical autonomy can be safely scaled?

👇 Drop A, B, or share your perspective.

[Afiqa Aulia @afiqau12]

@LifeNetwork_AI B

[Afiqa Aulia @afiqau12]

LifeAI boosts wellbeing through intelligent assessment.
@LifeNetwork_AI #LifeAI #healthcareAI https://t.co/BOff8iRIdW

[LIFE AI @LifeNetwork_AI]

💊 Community Question:
Can AI help discover and develop new medicines much faster and cheaper than traditional methods?

Viewpoint A:
Yes. AI can rapidly test millions of drug ideas, cut early research time and costs dramatically, and in some cases bring medicines to patients years faster.

Viewpoint B:
Not fully. AI helps at the start, but human trials are still slow, expensive, and unpredictable, keeping overall drug development costly and time-consuming.

If AI is expected to change how medicines are made, is the impact already real or mostly promise?

👇 Drop A, B, or share your perspective.

[LIFE AI @LifeNetwork_AI]

💊 Community Question:
Can AI help discover and develop new medicines much faster and cheaper than traditional methods?

Viewpoint A:
Yes. AI can rapidly test millions of drug ideas, cut early research time and costs dramatically, and in some cases bring medicines to patients years faster.

Viewpoint B:
Not fully. AI helps at the start, but human trials are still slow, expensive, and unpredictable, keeping overall drug development costly and time-consuming.

If AI is expected to change how medicines are made, is the impact already real or mostly promise?

👇 Drop A, B, or share your perspective.

[Afiqa Aulia @afiqau12]

@arazzaez @WhaleGames_en Skilled gambler😂

[Afiqa Aulia @afiqau12]

@toastpunk 0x5d2b8cccf9132b3795b2f5e6cd01f7ca90730d56

@ayunda608

[🍞ToastPunk.eth @toastpunk]

Trust wallet is being annoying. Looks like I’m forced to do a big airdrop to everyone to just make them know how real $USDDD and https://t.co/fyAGmLaX85 is.

Just drop as many BEP-20 wallet addresses you own and repost this. Tag friends.

Let’s show them who is boss.

[Afiqa Aulia @afiqau12]

@LifeNetwork_AI B

[Afiqa Aulia @afiqau12]

Healthcare meets intelligence. LifeAI meets you where you are.
#healthcareAI @LifeNetwork_AI #LifeAI https://t.co/5C9I4TUFSC

[LIFE AI @LifeNetwork_AI]

🩺 Community Question
Is personalized care realistic for low- and middle-income countries (LMICs), or is it still a model built mainly for high-income countries (HICs)?

Viewpoint A: Gradually achievable in LMICs
Personalized care can scale over time. Costs of genetic and digital tools are falling, AI-driven insights are becoming more accessible, and hybrid models already work in areas like oncology and chronic care. With the right partnerships and focus, personalization doesn’t have to remain a luxury.

Viewpoint B: Not practical for most LMICs
For many LMICs, personalized care remains unrealistic. High costs, limited infrastructure, workforce gaps, and unequal access make large-scale adoption difficult. Healthcare systems should prioritize proven, low-cost interventions like vaccination, screening, and basic prevention.

Or is the future of healthcare built by combining both approaches?

👇 Drop A, B, or share your perspective.
Tag someone who should weigh in on this.

[LIFE AI @LifeNetwork_AI]

🩺 Community Question
Is personalized care realistic for low- and middle-income countries (LMICs), or is it still a model built mainly for high-income countries (HICs)?

Viewpoint A: Gradually achievable in LMICs
Personalized care can scale over time. Costs of genetic and digital tools are falling, AI-driven insights are becoming more accessible, and hybrid models already work in areas like oncology and chronic care. With the right partnerships and focus, personalization doesn’t have to remain a luxury.

Viewpoint B: Not practical for most LMICs
For many LMICs, personalized care remains unrealistic. High costs, limited infrastructure, workforce gaps, and unequal access make large-scale adoption difficult. Healthcare systems should prioritize proven, low-cost interventions like vaccination, screening, and basic prevention.

Or is the future of healthcare built by combining both approaches?

👇 Drop A, B, or share your perspective.
Tag someone who should weigh in on this.

[Afiqa Aulia @afiqau12]

@arazzaez @Hana_Solana

[아라자에스 💜 @arazzaez]

.png Is the controller of the moon 🚀

The ticker is $PNG
CA:
58mWi7CzpsRjrDsv61BN1ynpNLoGHUbxAUeec141pump

[아라자에스 💜 @arazzaez]

CHIK the conqueror of the moon 🐓🚀